Standardized assessment of whole body adipose tissue topography by MRI

Journal of Magnetic Resonance Imaging

Volumn 21, Issue 4, 2005, Pages 455-462

  Machann, Jürgen ^a,c   Thamer, Claus ^a   Schnoedt, Birgit ^a   Haap, Michael ^a   Haring, Hans Ulrich ^a   Claussen, Claus D ^a   Stumvoll, Michael ^a,b   Fritsche, Andreas ^a   Schick, Fritz ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c Section on Experimental Radiology   (Germany)

Author keywords

Adipose tissue; Insulin sensitivity; Topography; Visceral adipose tissue; Whole body MRI

Indexed keywords

INSULIN;

ADIPOSE TISSUE; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY FAT; BODY MASS; FEMALE; HUMAN; IMAGE PROCESSING; INSULIN SENSITIVITY; MALE; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SEX DIFFERENCE; SUBCUTANEOUS FAT; WHOLE BODY SCANNER;

ADIPOSE TISSUE; ADULT; AGE FACTORS; AGED; ANTHROPOMETRY; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INSULIN RESISTANCE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED;

EID: 15944404922     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmri.20292     Document Type: Article

References (38)

1. Kissebah AH, Vydelingum N, Murray R, et al. Relation of body fat distribution to metabolic complications of obesity. J Clin Endocrinol Metab 1982;54:254-260.
2. Krotkiewski M, Bjorntorp P, Sjostrom L, Smith U. Impact of obesity on metabolism in men and women. Importance of regional adipose tissue distribution. J Clin Invest 1983;72:1150-1162.
3. Ohlson LO, Larsson B, Svardsudd K, et al. The influence of body fat distribution on the incidence of diabetes mellitus. 13.5 years of follow-up of the participants in the study of men born in 1913. Diabetes 1985;34:1055-1058.
4. Brodie DA, Stewart AD. Body composition measurement: a hierarchy of methods. J Pediatr Endocrinol Metab 1999;12:801-816.
5. Chan DC, Watts GF, Barrett PHR, Burke V. Waist circumference, waist-to-hip ratio and body mass index as predictors of adipose tissue compartments in men. QJM 2003;96:441-447.
6. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988;37:1595-1607.
7. Kahn BB, Flier JS. Obesity and insulin resistance. J Clin Invest 2000;106:473-481.
8. Kissebah AH. Central obesity: measurement and metabolic effects. Diabetes Rev 1997;5:8-20.
9. Wajchenberg BL. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 2000;21:697-738.
10. Shen W, Wang Z, Punyanita M, et el. Adipose tissue quantification by imaging methods: a proposed classification. Obes Res 2003;11:5-16.
11. Abate N, Burns D, Peshock R, Garg A, Grundy S. Estimation of adipose tissue mass by magnetic resonance imaging: validation against dissection in human cadavers. J Lipid Res 1994;35:1490-1496.
12. Mitsiopoulos N, Baumgartner RN, Heymsfield SB, Lyons W, Gallagher D, Ross R. Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography. J Appl Physiol 1998;85:115-122.
13. Raji A, Seely EW, Arky R, Simonson DC. Body fat distribution and insulin resistance in healthy Asian Indians and Caucasians. J Clin Endocrinol Metab 2001;86:5366-5371.
14. Ross R, Shaw KD, Martel Y, de Guise J, Avruch L. Adipose tissue distribution measured by magnetic resonance imaging in obese women. Am J Clin Nutr 1993;57:470-475.
15. Ross R, Leger L, Morris D, de Guise J, Guardo R. Quantification of adipose tissue by MRI: relationship with anthropometric variables. J Appl Physiol 1992;72:787-795.
16. Thomas EL, Saeed N, Hajnal JV, et al. Magnetic resonance imaging of total body fat. J Appl Physiol 1998;85:1778-1785.
17. Schick F, Eismann B, Jung WI, Bongers H, Bunse M, Lutz O. Comparison of localized proton NMR signals of skeletal muscle and fat tissue in vivo: two lipid compartments in muscle tissue. Magn Reson Med 1993;29:158-167.
18. Poon CS, Szumowski J, Plewes DB, Ashby P, Henkelman RM. Fat/water quantitation and differential relaxation time measurement using chemical shift imaging technique. Magn Reson Imaging. 1989;7:369-382.
19. Lunati E, Marzola P, Nicolato E, Sbarbati A. In-vivo quantitative hydrolipidic map of perirenal adipose tissue by chemical shift imaging at 4.7 Tesla. Int J Obes Relat Metab Disord 2001;25:457-461.
20. Schick F, Machann J, Brechtel K, et al. MRI of muscular fat. Magn Reson Med 2002;47:720-727.
21. Huang TY, Chung HW, Wang FN, Ko CW, Chen CY. Fat and water Separation in balanced steady-state free precession using the Dixon method. Magn Reson Med 2004;51:243-247.
22. Donnelly LF, O'Brien KJ, Dardzinski BJ, et al. Using a phantom to compare MR techniques for determining the ratio of intraabdominal to subcutaneous adipose tissue. AJR Am J Roentgenol 2003;180:993-998.
23. Miyazaki Y, Glass L, Triplitt C, Wajcberg E, Mandarino LJ, DeFronzo RA. Abdominal fat distribution and peripheral and hepatic insulin resistance in type 2 diabetes mellitus. Am J Physiol Endocrinol Metab 2002;283:E1135-E1143.
24. Janssen I, Heymsfield SB, Allison DB, Kotler DP, Ross R. Body mass index and waist circumference independently contribute to the prediction of nonabdominal, abdominal subcutaneous, and visceral fat. Am J Clin Nutr 2002;75:683-688.
25. Ryysy L, Hakkinen AM, Goto T, et al. Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients. Diabetes 2000;49:749-758.
26. Münzer T, Harman SM, Hees P, et al. Effects of GH and/or sex steroid administration on abdominal subcutaneous and visceral fat in healthy aged women and men. J Clin Endocrinol Metab 2001;86:3604-3610.
27. Janssen I, Hudson R, Fortier A, Ross R. Effects of an energy-restrictive diet with or without exercise on abdominal fat, intermuscular fat, and metabolic risk factors in obese women. Diabetes Care 2002;25:431-438.
28. Tiikkainen M, Bergholm R, Rissanen A, et al. Effects on equal weight loss with orlistat and placebo on body fat and serum fatty acid composition and insulin resistance in obese women. Am J Clin Nutr 2004;79:22-30.
29. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979;237:E214-E223.
30. Abate N, Garg A, Peshock RM, Stray-Gundersen J, Adams-Huet B, Grundy SM. Relationship of generalized and regional adiposity to insulin sensitivity in men with NIDDM. Diabetes 1996;45:1684-1693.
31. Abate N, Garg A, Peshock RM, Stray-Gundersen J, Grundy SM. Relationships of generalized and regional adiposity to insulin sensitivity in men. J Clin Invest 1995;96:88-98.
32. Van der Kooy K, Leenen R, Seidell JC, Deurenberg P, Visser M. Abdominal diameters as indicators of visceral fat: comparison between magnetic resonance imaging and anthropometry. Br J Nutr 1993;70:47-58.
33. Shadid S, Jensen MD. Effects of Pioglitazone versus diet and exercise on metabolic health and fat distribution in upper body obesity. Diabetes Care 2003;26:3148-3152.
34. Jacob S, Machann J, Rett K, et al. Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects. Diabetes 1999;48:1113-1119.
35. Perseghin G, Scifo P, De Cobelli F, et al. Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a 1H-13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents. Diabetes 1999;48:1600-1606.
36. Virkamaki A, Korsheninnikova E, Seppala-Lindroos A, et al. Intramyocellular lipid is associated with resistance to in vivo insulin actions on glucose uptake, antilipolysis, and early insulin signaling pathways in human skeletal muscle. Diabetes 2001;50:2337-2343.
37. Seppala-Lindroos A, Vehkavaara S, Hakkinen AM, et al. Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. J Clin Endocrinol Metab 2002;87:3023-3028.
38. Thamer C, Machann J, Bachmann O, et al. Intramyocellular lipids: anthropometric determinants and relationships with maximal aerobic capacity and insulin sensitivity. J Clin Endocrinol Metab 2003;88:1785-1791.